Literature DB >> 1466153

DNA-cytophotometry and immunocytochemistry in ovarian tumours of borderline malignancy and related peritoneal lesions.

B C Padberg1, H E Stegner, S von Sengbusch, H Arps, S Schröder.   

Abstract

A total of 34 surgical specimens, obtained from 13 patients with ovarian tumours of borderline malignancy (OTBM), were investigated by conventional histology, immunocytochemistry and DNA cytophotometry. The lesions were obtained by primary ovarian surgery or second-look procedures and altogether comprised 19 (single and bilateral) OTBM, 8 cases of endosalpingiosis, 4 in situ and 2 invasive peritoneal implants and 1 overt adenocarcinoma. The morphological findings were related to follow-up data, which showed neoplasms with clinically malignant behaviour in 2 patients. The histology of the extra-ovarian manifestations was not associated with their immunocytochemical properties or with their DNA content. There were no correlations between the evolution of disease and microscopical features but the clinical course appeared to be linked to the DNA content of the extra-ovarian lesions, which was of greater prognostic importance than DNA ploidy of the ovarian tumours. Recurrence-free survival was noted in all 5 patients with diploid or euploid extra-ovarian proliferations, while the 2 clinically malignant cases fell into the group of 3 patients with noneuploid or aneuploid specimens. DNA estimations may be a methodology which increases the prognostic value of second-look procedures in OTBM patients.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1466153     DOI: 10.1007/bf01606879

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  43 in total

1.  Changes in definitions of clinical staging for carcinoma of the cervix and ovary: International Federation of Gynecology and Obstetrics.

Authors: 
Journal:  Am J Obstet Gynecol       Date:  1987-01       Impact factor: 8.661

2.  Immunohistochemistry in the differential diagnosis in the second-look operation for ovarian carcinomas.

Authors:  J C Manivel; M R Wick; C M Coffin; L P Dehner
Journal:  Int J Gynecol Pathol       Date:  1989       Impact factor: 2.762

3.  DNA content and survival in mammary carcinoma.

Authors:  G U Auer; T O Caspersson; A S Wallgren
Journal:  Anal Quant Cytol       Date:  1980-09

4.  Papillary peritoneal neoplasms in females.

Authors:  W T McCaughey
Journal:  Pathol Annu       Date:  1985

5.  Surface (germinal) epithelium and related ovarian neoplasms.

Authors:  A Blaustein
Journal:  Pathol Annu       Date:  1981

6.  Peritoneal implants of ovarian serous borderline tumors. Histologic features and prognosis.

Authors:  D A Bell; M A Weinstock; R E Scully
Journal:  Cancer       Date:  1988-11-15       Impact factor: 6.860

7.  Proliferative serous tumors of the ovary. Histologic features and prognosis.

Authors:  A L Katzenstein; M T Mazur; T E Morgan; M S Kao
Journal:  Am J Surg Pathol       Date:  1978-12       Impact factor: 6.394

8.  Distinguishing lymph node metastases from benign glandular inclusions in low-grade ovarian carcinoma.

Authors:  R L Ehrmann; J M Federschneider; R C Knapp
Journal:  Am J Obstet Gynecol       Date:  1980-03-15       Impact factor: 8.661

9.  Conservative treatment of borderline ovarian tumors.

Authors:  H D Tazelaar; D G Bostwick; S C Ballon; M R Hendrickson; R L Kempson
Journal:  Obstet Gynecol       Date:  1985-09       Impact factor: 7.661

10.  Nuclear deoxyribonucleic acid heterogeneity of ovarian borderline malignant serous tumors.

Authors:  Y S Fu; J Ro; J W Reagan; T L Hall; J Berek
Journal:  Obstet Gynecol       Date:  1986-04       Impact factor: 7.661

View more
  1 in total

1.  Comparative DNA analysis by image cytometry and flow cytometry in non-small cell lung cancer.

Authors:  T Yamamoto; H Horiguchi; H Kamma; M Noro; T Ogata; Y Inage; E Akaogi; K Mitsui; M Hori; M Isobe
Journal:  Jpn J Cancer Res       Date:  1994-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.